Additional information from the published procurement release. Fields appear only when supplied by the source; check the original notice and tender documents before acting.
2 published notice versions reviewed by ProcuraAxis.
2 VERSIONS
1
094370-2026Preliminary market engagement notice on Find a Tender ·
2
098045-2026Tender notice on Find a Tender ·
PROCURAAXIS ANALYSIS
ProcuraAxis Analysis
Our approved analysis of the opportunity appears below the official tender information.
ANALYSIS PREVIEW
Opportunity intelligence at a glance
Open tender for the provision of PET-CT radiopharmaceuticals to Health Boards in Wales.
Who this may suit
Relevant to suppliers able to provide radiopharmaceuticals for positron emission tomography (PET-CT). Detailed technical, regulatory, eligibility and commercial requirements are not provided in the supplied notice data.
Key points identified
Required product scopeRadiopharmaceuticals for use in Positron Emission Tomography (PET-CT)Evidence: "Tender for the provision of Radiopharmaceuticals for use in Positron Emission Tomography (PET-CT) to Health Boards in Wales."
Supplier eligibility requirementsUnknownEvidence: No eligibility criteria are included in the supplied opportunity data.
Maximum stated valueGBP 16,238,199.99Evidence: process.value_max: 16238199.99 GBP; lot 1 value_amount: 16238199.99 GBP.
91% approved-analysis confidence2 supplier criteria identified3 risks or unknowns
ProcuraAxis structures information found in published procurement records, checks the result for consistency and publishes only approved analysis. Confidence describes the completeness and consistency of the available source information; it is not a guarantee of eligibility or contract award.
Open tender for the provision of PET-CT radiopharmaceuticals to Health Boards in Wales.
Who this may suit
Relevant to suppliers able to provide radiopharmaceuticals for positron emission tomography (PET-CT). Detailed technical, regulatory, eligibility and commercial requirements are not provided in the supplied notice data.
Key deliverables
Radiopharmaceuticals for PET-CT use
Provision to Health Boards in Wales
SUPPLIER REQUIREMENTS
2 criteria identified
Required product scope
99% confidence
Radiopharmaceuticals for use in Positron Emission Tomography (PET-CT)
View supporting evidence
"Tender for the provision of Radiopharmaceuticals for use in Positron Emission Tomography (PET-CT) to Health Boards in Wales."
Supplier eligibility requirements
99% confidence
Unknown
View supporting evidence
No eligibility criteria are included in the supplied opportunity data.
COMMERCIAL AND DELIVERY
Contract intelligence
Commercial
Maximum stated value
94% confidence
GBP 16,238,199.99
View supporting evidence
process.value_max: 16238199.99 GBP; lot 1 value_amount: 16238199.99 GBP.
Contract term
99% confidence
Unknown
View supporting evidence
Contract start and end dates are null in the supplied data.
Delivery
Delivery area
98% confidence
Wales, United Kingdom
View supporting evidence
Delivery location region is "UKL"; the description states provision "to Health Boards in Wales."
Delivery timetable and logistics
99% confidence
Unknown
View supporting evidence
No delivery schedule, sites, volumes or logistics requirements are included in the supplied data.
process.submission_deadline: "2026-11-17T12:00:00+00:00"; lot 1 has the same deadline.
Notice
99% confidence
Tender notice on Find a Tender
View supporting evidence
process.notice_type: "Tender notice on Find a Tender".
RISKS AND UNKNOWNS
Points requiring attention
Detailed specification unavailable
99% confidence
Technical specifications, product list, quantities, regulatory requirements, quality requirements and evaluation criteria are unknown from the supplied data.
View supporting evidence
The supplied description only identifies radiopharmaceuticals for PET-CT; no tender documents or detailed specifications are supplied.
Commercial terms unavailable
98% confidence
Pricing structure, contract duration, call-off arrangements and payment terms are unknown.
View supporting evidence
Only a maximum stated value is supplied; contract start/end dates are null and no commercial documents are provided.
Lot information incomplete
99% confidence
A single active lot is present with no title or description; its relationship to the overall scope is not described.
View supporting evidence
Lot 1 has title null and description null.
ProcuraAxis analysis supplements, but does not replace, the original notice and tender documents. Always verify eligibility, deadlines and commercial terms with the issuing authority.
Continue in your ProcuraAxis workspaceFree account · Full approved analysis